Quantcast
Channel: BioTuesdays » cardiology
Browsing latest articles
Browse All 4 View Live

Image may be NSFW.
Clik here to view.

BioLineRx pipeline returns to the winner’s circle

After disappointing investors in March by terminating a Phase 2/3 clinical trial of an anti-psychotic drug candidate for the treatment of schizophrenia, BioLineRx (NASDAQ:BLRX; TASE:BLRX) bounced back...

View Article



Image may be NSFW.
Clik here to view.

James Gandolfini’s death highlights risk factors for heart attack

The recent and widely reported death of actor James Gandolfini highlights the need to aggressively address the known risk factors for heart attack and sudden cardiac death. George Jackowski “Omega-3...

View Article

Image may be NSFW.
Clik here to view.

Interface, Q3 in Kinesyx development pact

Closely-held Interface Biologics of Toronto and Q3 Medical Devices have signed a joint development and commercialization agreement to combine Interface’s Kinesyx bioactive oligomers with the balloon...

View Article

Image may be NSFW.
Clik here to view.

Amarantus posts positive preclinical data for retinitis pigmentosa

Amarantus BioScience Holdings (OTCQB:AMBS) has announced positive effects of Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF) for the protection from vision loss in an animal model of...

View Article
Browsing latest articles
Browse All 4 View Live




Latest Images